BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25824218)

  • 1. Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.
    Burton AJ; Giguère S; Berghaus LJ; Hondalus MK
    Antimicrob Agents Chemother; 2015; 59(6):3633-6. PubMed ID: 25824218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
    Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
    J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages.
    Burton AJ; Giguère S; Berghaus LJ; Hondalus MK; Arnold RD
    Vet Microbiol; 2015 Apr; 176(3-4):292-300. PubMed ID: 25666452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Macrolide and Rifampin Resistance on Fitness of
    Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
    Baraia-Etxaburu J; Malero P; Unzaga MJ; Teira R; Muñoz J; Cisterna R; Santamaría JM
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):274-5. PubMed ID: 9376391
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
    Berghaus LJ; Giguère S; Guldbech K
    Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.
    Giguère S; Lee EA; Guldbech KM; Berghaus LJ
    Vet Microbiol; 2012 Nov; 160(1-2):207-13. PubMed ID: 22704561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and therapy of Rhodococcus equi infection in the horse].
    Boswinkel M; Sloet van Oldruitenborgh-Oosterbaan MM
    Tijdschr Diergeneeskd; 2006 Sep; 131(17):602-11. PubMed ID: 16989420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
    Boyen F; Pasmans F; Haesebrouck F
    Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of Rhodococcus equi disseminated infections in nude mice.
    Nordmann P; Kerestedjian JJ; Ronco E
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1244-8. PubMed ID: 1416823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Resistance in
    Giguère S; Berghaus LJ; Willingham-Lane JM
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
    Huber L; Giguère S; Slovis NM; Carter CN; Barr BS; Cohen ND; Elam J; Erol E; Locke SJ; Phillips ED; Smith JL
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
    Mascellino MT; Iona E; Ponzo R; Mastroianni CM; Delia S
    Int J Clin Pharmacol Res; 1994; 14(5-6):157-63. PubMed ID: 7672872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatment.
    Rampacci E; Marenzoni ML; Chiaradia E; Passamonti F; Ricci M; Pepe M; Coletti M; Giovagnoli S
    Sci Rep; 2018 Aug; 8(1):12149. PubMed ID: 30108265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tulathromycin, azithromycin and azithromycin-rifampin for the treatment of mild pneumonia associated with Rhodococcus equi.
    Venner M; Credner N; Lämmer M; Giguère S
    Vet Rec; 2013 Oct; 173(16):397. PubMed ID: 24106244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Rhodococcus equi Infections Based on Immune Status and Antibiotic Susceptibility of Clinical Isolates in a Case Series of 12 Patients and Cases in the Literature.
    Gundelly P; Suzuki Y; Ribes JA; Thornton A
    Biomed Res Int; 2016; 2016():2737295. PubMed ID: 27631004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good response to antibiotic treatment of lung infection due to Rhodococcus equi in a patient infected with human immunodeficiency virus.
    Sasal M; Roig J; Cervantes M; Matas L; Segura F
    Clin Infect Dis; 1992 Oct; 15(4):747-8. PubMed ID: 1420703
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin.
    Moretti F; Quiros-Roldan E; Casari S; Viale P; Chiodera A; Carosi G
    AIDS; 2002 Jul; 16(10):1440-2. PubMed ID: 12131231
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia.
    Giguère S; Jacks S; Roberts GD; Hernandez J; Long MT; Ellis C
    J Vet Intern Med; 2004; 18(4):568-73. PubMed ID: 15320600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of oral clarithromycin in foals.
    Jacks S; Giguère S; Gronwall RR; Brown MP; Merritt KA
    J Vet Pharmacol Ther; 2002 Oct; 25(5):359-62. PubMed ID: 12423226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.